Christine Desmedt
Katholieke Universiteit Leuven
H-index: 68
Europe-Belgium
Top articles of Christine Desmedt
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Rapid autopsies to enhance metastatic research: the UPTIDER post-mortem tissue donation program | npj Breast Cancer | Tatjana Geukens Maxim De Schepper Wouter Van Den Bogaert Karen Van Baelen Marion Maetens | 2024/4/24 |
Abstract PO2-11-09: European Lobular Breast Cancer Advocates: Bridging the Geographical Gaps in Lobular Breast Cancer Education and Awareness | Cancer Research | Siobhan Freeney Helene Bonval Esther Geven Lori Petitti Rian Terveer | 2024/5/2 |
Abstract PO2-07-09: Early stage invasive lobular breast cancer is underestimated on conventional imaging including MRI | Cancer Research | Kaat Van Herck Karen Van Baelen Chantal Van Ongeval Valerie Celis Helen De Boodt | 2024/5/2 |
Chemotherapy-drivende novoWnt pathway activation dictates a dynamic shift to a drug-tolerant state in breast cancer cells | Y El Laithy WA Abreu De Oliveira A Pabba A Qualizza F Richard | 2024/3/12 | |
Transcriptomic characterization of the histopathological growth patterns in breast cancer liver metastases | Clinical & Experimental Metastasis | Sophia Leduc Ha-Linh Nguyen François Richard Gitte Zels Amena Mahdami | 2024/3/29 |
Integration of pathological criteria and immunohistochemical evaluation for invasive lobular carcinoma diagnosis: recommendations from the European Lobular Breast Cancer Consortium | Modern Pathology | Maxim De Schepper Thijs Koorman François Richard Matthias Christgen Anne Vincent-Salomon | 2024/4/17 |
Abstract PO1-14-11: Different molecular processes are associated with recurrence in the clinical high-genomic low risk (cH/gL) and clinical low-genomic high risk (cL/gH) groups … | Cancer Research | Christine Desmedt Ha-Linh Nguyen François Richard Marion Maetens Coralie Poncet | 2024/5/2 |
Abstract PS06-01: Results from a pilot study exploring ctDNA detection using a tumor-informed assay in the monarchE trial of adjuvant abemaciclib with endocrine therapy in HR+ … | Cancer Research | Sherene Loi Stephen Johnston Carlos Arteaga Stephanie Graff Sarat Chandarlapaty | 2024/5/2 |
Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions | Oncogene | C-R Pradeep A Zeisel WJ Köstler M Lauriola J Jacob-Hirsch | 2024/2/28 |
Highly populated phylogenetic reconstruction in patients with hormone receptor positive-HER2 non-amplified metastatic breast cancer | Cancer Research | Francois Richard Tatjana Geukens Maxim De Schepper Amena Mahdami Karen Van Baelen | 2024/3/22 |
Metastases of primary mixed no-special type and lobular breast cancer display an exclusive lobular histology | The Breast | Gitte Zels Karen Van Baelen Maxim De Schepper Kristien Borremans Tatjana Geukens | 2024/4/12 |
Abstract PO5-21-10: Efficacy and Safety of Alpelisib in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor: An Open-label, Multi-centre … | Cancer Research | Rik Van Severen Anne-Sofie De Crem Hava Izci Laurence Slembrouck Isabelle Vanden Bempt | 2024/5/2 |
Abstract PO3-05-05: The effect of histological breast cancer subtype on progression free survival in patients with CDK4/6 inhibitors | Cancer Research | Cedric Bauters Karen Van Baelen Hans Wildiers Giuseppe Floris Sileny Han | 2024/5/2 |
Abstract A004: Comparison of ctDNA detection in seven different types of body liquids from patients with metastatic breast cancer | Cancer Research | François Richard Tatjana Geukens Maxim De Schepper Amena Mahdami Karen Van Baelen | 2024/2/1 |
Heterogeneity of the hormone receptor-positive breast tumor immune microenvironment according to patient’s body mass index | Cancer Research | Ha-Linh Nguyen Tatjana Geukens Maxim De Schepper Karen Van Baelen Marion Maetens | 2024/3/22 |
Global post-mortem tissue donation programmes to accelerate cancer research | Christine Desmedt Lisa A Carey | 2024/4/8 | |
Abstract PO1-06-06: Underestimation of metastatic spread in patients with lobular breast cancer: results from the post-mortem tissue donation program UPTIDER | Cancer Research | Karen Van Baelen Gitte Zels Maxim De Schepper Marion Maetens Josephine Van Cauwenberge | 2024/5/2 |
Abstract GS03-06: Genomic and transcriptomic profiling of primary tumors from patients with HR+, HER2-, node-positive, high-risk early breast cancer in the monarchE trial | Cancer Research | Nicholas Turner Jorge Reis-Filho Matthew Goetz Christine Desmedt Sarat Chandarlapaty | 2024/5/2 |
Treatment Response, Tumor Infiltrating Lymphocytes and Clinical Outcomes in Inflammatory Breast Cancer–Treated with Neoadjuvant Systemic Therapy | Cancer Research Communications | Maxim De Schepper Ha-Linh Nguyen François Richard Louise Rosias Florence Lerebours | 2024/1/24 |
Reporting on invasive lobular breast cancer in clinical trials: a systematic review | Karen Van Baelen Josephine Van Cauwenberge Marion Maetens Gabriela Beck Ann Camden | 2024/3/20 |
